NUR02 - IMPLEMENTATION OF A NURSING-LED REMOTE EVALUATION FOR THE ASSESSMENT AND PRIORITIZATION OF ADOLESCENTS WITH HEAVY MENSTRUAL BLEEDING
NUR02
IMPLEMENTATION OF A NURSING-LED REMOTE EVALUATION FOR THE ASSESSMENT AND PRIORITIZATION OF ADOLESCENTS WITH HEAVY MENSTRUAL BLEEDING
C. Benedicto Moreno1,2,3,*, A. Gómez3,4, M. Mesegué-Medà1,2,3,5, R. Berrueco 1,2,3,5, P. Estival1,2,3,5, A. Pallache1,2,3,5, R. Pascal3,4, C. Salvador3,4, S. González3,4, M. Arraez3,4, N. Caballero-Mencía1,2,3
1Peadiatric Haematology, 2SJD-HSP Integrated Hemophilia Unit, 3Heavy Menstrual Bleeding Unit, 4Gyneacology and Obstetrics Department, 5Research Institute, Hospital Sant Joan de Déu, Barcelona, Spain
Introduction: Heavy menstrual bleeding (HMB) is a frequent reason for consultation in adolescents. Immaturity of the hypothalamic–pituitary–ovarian axis is the most common aetiology, but underlying bleeding disorders must also be considered. Since 2021, our institution has run a multidisciplinary unit for comprehensive evaluation of adolescents with HMB, integrating haematology, gynaecology, and specialized nursing. The exponential rise in referrals prompted implementation of a nursing-led evaluation to enhance triage, prioritize care, and optimize management.
Aim: To implement a structured nursing remote evaluation for assessment and prioritization of adolescents with suspected HMB before their first face-to-face appointment in the multidisciplinary unit, and to evaluate its clinical and organizational contributions.
Methods: Descriptive study within a tertiary hospital adolescent HMB program. The intervention started in November 2024 and consisted of a structured telephone interview conducted 2–3 months before the appointment. The assessment included menstrual and bleeding history, standardized haemorrhagic risk evaluation using the ISTH-BAT and Paediatric Bleeding Questionnaire, delivery and explanation of the Pictorial Bleeding Assessment Chart (PBAC), and solving patients’ concerns. A multidisciplinary subjective evaluation assessed the usefulness of this strategy.
Results: From November 2024 to October 2025, 57 teleconsultations were completed. In 5.2% of cases, the in-person appointment was expedited due to clinical warning signs, including anaemia or persistent profuse bleeding. The multidisciplinary team reported that prior evaluations facilitated in-depth discussion during assessment, as essential data were already collected. Systematic use of PBAC contributed to diagnostic standardization before therapeutic decisions and enabled monitoring of treatment effectiveness through pre- and post-intervention score comparison.
Discussion/Conclusion: Nursing-led remote evaluation could help to improve quality and efficiency of care for adolescents with HMB by ensuring early detection of high-risk cases, providing clinical data, and enhancing preparedness of the multidisciplinary team. This approach promotes adolescent engagement and supports timely, individualized, and comprehensive management.
Disclosure of Interest: C. Benedicto Moreno Consultant for: Pfizer , Speaker Bureau of: Roche, Sobi, A. Gómez: None declared, M. Mesegué-Medà: None declared, R. Berrueco Grant/Research support from: Roche and SOBI, Consultant for: Roche, SOBI, Pfizer, Novo Nordisk, Speaker Bureau of: Takeda, Roche, Bayer, CSL-Behring, Novo Nordisk, Sobi, Octapharma, Amgen, Werfen, Stago, Boeringer Ingelheim and Pfizer., P. Estival Grant/Research support from: Roche, A. Pallache Grant/Research support from: Roche, R. Pascal: None declared, C. Salvador: None declared, S. González: None declared, M. Arraez: None declared, N. Caballero-Mencía Consultant for: Novo Nordisk, Speaker Bureau of: Sobi, Roche